Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens

World Health Organization (WHO). (Report 2018), https://www.who.int/malaria/publications/world-malaria-report-2018/en/. World Health Organization (WHO). (Report 2018), https://www.who.int/tb/publications/global_report/en/. Powles, 2012, MK-4815, a potential new oral agent for treatment of malaria, Antimicrob Agents Chemother, 56, 2414, 10.1128/AAC.05326-11 Brunschwig, 2018, UCT943, a Next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria, Antimicrob Agents Chemother, 27, e00012 Miley, 2015, ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria, Antimicrob Agents Chemother, 59, 5555, 10.1128/AAC.01183-15 Phyo, 2016, Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria:an open-label phase 2 trial, Lancet Infect Dis, 16, 61, 10.1016/S1473-3099(15)00320-5 White, 2014, Spiroindolone KAE609 for falciparum and vivax malaria, N Engl J Med, 371, 403, 10.1056/NEJMoa1315860 Bélard, 2018, DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria, Lancet Infect Dis, 18, 819, 10.1016/S1473-3099(18)30374-8 Okombo, 2018, Recent updates in the discovery and development of novel antimalarial drug candidates, MedChemComm, 9, 437, 10.1039/C7MD00637C Pethe, 2013, Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis, Nat Med, 19, 1157, 10.1038/nm.3262 Sutherland, 2019, 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel, Bioorg Med Chem, 27, 1292, 10.1016/j.bmc.2019.02.026 TB Alliance, Institute of Materia Medica. Phase 1a began January 16, 2019. Placebo-Controlled, Randomized, SAD Study to Evaluate the Safety, Tolerability, and PK of TBI-223 in Healthy NCT03758612. https://www.newtbdrugs.org/pipeline/compound/tbi-223. Accessed on 27th September 2019. Cox, 2014, FDA approval of bedaquiline-the benefit-risk balance for drug-resistant tuberculosis, N Engl J Med, 371, 689, 10.1056/NEJMp1314385 https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs. Accessed on 30th September 2019. Turner, 1962, Pyrvinium pamoate in the treatment of pinworm infection (enterobiasis) in the home, J Pediatr, 60, 243, 10.1016/S0022-3476(62)80042-0 Beck, 1959, The treatment of pinworm infections in humans (enterobiasis) with pyrvinium chloride and pyrvinium pamoate, Am J Trop Med Hyg, 8, 349, 10.4269/ajtmh.1959.8.349 Cho, 1977, Evaluation of anthelmintic treatment of Enterobius vermicularis infection in highly endemic population by prolonged observation, Korean J Parasitol, 15, 100, 10.3347/kjp.1977.15.2.100 Royer, 1962, Pinworm infestation in children: the problem and its treatment, Can Med Assoc J, 86, 60 Desai, 1962, Single-dose treatment of oxyuriasis with pyrvinium embonate, Br Med J, 2, 1583, 10.1136/bmj.2.5319.1583 Sudigbia, 1970, Single-dose treatment of oxyuriasis with pyrvinium pamoate (Vanquin), Paediatr Indones, 10, 125 Lougheed, 2009, New anti-tuberculosis agents amongst known drugs, Tuberculosis, 89, 364, 10.1016/j.tube.2009.07.002 Torres, 2016, Screening a commercial library of pharmacologically active small molecules against Staphylococcus aureus biofilms, Antimicrob Agents Chemother, 60, 5663, 10.1128/AAC.00377-16 Siles, 2013, High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors, Antimicrob Agents Chemother, 57, 3681, 10.1128/AAC.00680-13 Esumi, 2004, Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation, Cancer Sci, 95, 685, 10.1111/j.1349-7006.2004.tb03330.x Downey, 2009, In vitro activity of pyrvinium pamoate against Entamoeba histolytica and Giardia intestinalis using radiolabelled thymidine incorporation and an SYBR Green I-based fluorescence assay, J Antimicrob Chemother, 64, 751, 10.1093/jac/dkp296 Chong, 2006, A clinical drug library screen identifies astemizole as an antimalarial agent, Nat Chem Biol, 2, 415, 10.1038/nchembio806 Makane, 2019, Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis, Eur J Med Chem, 164, 665, 10.1016/j.ejmech.2019.01.002 Makane, 2019, Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. Fut, Med Chem, 11, 499 Kotapalli, 2015, Identification of new molecular entities (NMEs) as potential leads against tuberculosis from open source compound repository, PLoS ONE, 10, 10.1371/journal.pone.0144018 Lade, 2017, A facile synthesis and antituberculosis properties of almazole D and its enantiomer, ChemistrySelect, 2, 1250, 10.1002/slct.201601821 Karale, 2019, Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis, Eur J Med Chem, 178, 315, 10.1016/j.ejmech.2019.05.082 Rode, 2019, Strategies towards the synthesis of anti-tuberculosis drugs, Org Biomol Chem, 17, 5428, 10.1039/C9OB00817A Macdonald JE, Hysell MK, Yu D, Li H, Wong-Staal F. Novel quinolinium salts and derivatives. WO2006/078754 A1; 2006. Mao, 2012, New synthesis of pyrvinium that inhibits the β-catenin/Tcf4 pathway, Heterocycles, 85, 1179, 10.3987/COM-12-12446 Teguh, 2013, Novel conjugated quinoline-indoles compromise Plasmodium falciparum mitochondrial function and show promising antimalarial activity, J Med Chem, 56, 6200, 10.1021/jm400656s